Clinical Trial Update: Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and biological effects of ILP100-Topical in diabetic foot ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Impaired Wound Healing

Drugs mentioned

• ILP100-Topical

Snippet

Sponsor: Ilya Pharma | Conditions: Wound Heal, Wound Healing Disturbance of | Phase 2 | Status: TERMINATED